In a recent trademark infringement case involving Dr. Reddy\u2019s Laboratories Limited (“Dr. Reddy’s”) and Rebanta Healthcare Pvt Ltd and another defendant (collectively “Rebanta”), the Delhi High Court granted interim relief to Dr. Reddy\u2019s. Dr. Reddy’s sought a permanent injunction to restrain Rebanta from using the trademark “REBAHEAL” claiming that Rebanta’s use of the identical mark infringed upon Dr. Reddy’s statutory and common law rights.<\/p>\n
Dr. Reddy\u2019s claimed that it is the registered proprietor of the “REBAHEAL” trademark, which it coined and has been using since June 2023 for a product containing the active ingredient Rebamipide, intended for the treatment of peptic and mouth ulcers.<\/p>\n
In June 2024, Dr. Reddy\u2019s discovered that Rebanta was manufacturing, marketing, and selling pharmaceutical products under the “REBAHEAL” mark. \u00a0Considering that the defendants were using the mark \u201cREBAHEAL\u201d for a product for the treatment of pain, regulating menstruation, and aiding bone repair, Dr. Reddy\u2019s contended that the dishonest, adoption of an identical mark by Rebanta could result in disastrous consequences if the wrong product was dispensed, prescribed, or taken.<\/p>\n
Dr. Reddy\u2019s also contended that Rebanta\u2019s use of the identical mark \u201cREBAHEAL\u201d constituted trademark infringement and passing off, and Rebanta was trying to benefit from the established reputation and goodwill of \u201cREBAHEAL\u201d by adopting an identical trademark.<\/p>\n
In view of the contentions put forth by the parties, the Hon\u2019ble Court observed that the Dr. Reddy\u2019s had made a strong prima facie case for themselves, and the balance of convenience lay in their favor. While pronouncing its decision, the Court observed as follows:<\/p>\n
Accordingly, the court issued an order restraining Rebanta from manufacturing, marketing, or selling any products under the “REBAHEAL” mark or any other mark deceptively similar to Dr. Reddy’s trademark until the next hearing.<\/p>\n
Authored by Ms. Ilana Baruah, Consulting and Strategy Team, BananaIP Counsels<\/strong><\/p>\n Citation:<\/strong> Dr. Reddys Laboratories Limited v. Rebanta Healthcare Pvt Ltd & Anr, Delhi High Court, 9th<\/sup> July, 2024, [CS(COMM) 553\/2024 & I.A. Nos. 32621\/2024, 32622\/2024, 32623\/2024 & 32624\/2024] Available at: https:\/\/indiankanoon.org\/doc\/145689256\/<\/a><\/p>\n The case note\/s in this blog post have been written by IP Attorneys at BananaIP Counsels based on their review and understanding of the Judgments. It may be noted that other IP attorneys and experts in the field may have different opinions about the cases or arrive at different conclusions therefrom. It is advisable to read the Judgments before making any decisions based on the case notes.<\/p>\n If you have any questions, or if you wish to speak with an\u00a0IP expert\/attorney<\/a>, please reach us at:\u00a0contact@bananaip.com<\/a>\u00a0or 91-80-26860414\/24\/34.<\/p>\n","protected":false},"excerpt":{"rendered":" The Delhi High Court has issued an interim order restraining Rebanta Healthcare from using the REBAHEAL mark following a trademark infringement suit by Dr. Reddy\u2019s. The court found the marks identical, raising concerns of public confusion and health risks.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"iawp_total_views":16,"footnotes":""},"categories":[5495,6,11],"tags":[486,551,110,1160,6021,6164,11847,41],"class_list":["post-113553","post","type-post","status-publish","format-standard","hentry","category-case-reviews","category-intellectual-property","category-trademarks","tag-delhi-high-court","tag-dr-reddys-laboratories","tag-intellectual-property-law-2","tag-passing-off","tag-pharmaceutical-trademarks","tag-rebaheal","tag-rebanta-healthcare","tag-trademark-infringement-2"],"_links":{"self":[{"href":"https:\/\/www.bananaip.com\/intellepedia\/wp-json\/wp\/v2\/posts\/113553","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bananaip.com\/intellepedia\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bananaip.com\/intellepedia\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bananaip.com\/intellepedia\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bananaip.com\/intellepedia\/wp-json\/wp\/v2\/comments?post=113553"}],"version-history":[{"count":3,"href":"https:\/\/www.bananaip.com\/intellepedia\/wp-json\/wp\/v2\/posts\/113553\/revisions"}],"predecessor-version":[{"id":143640,"href":"https:\/\/www.bananaip.com\/intellepedia\/wp-json\/wp\/v2\/posts\/113553\/revisions\/143640"}],"wp:attachment":[{"href":"https:\/\/www.bananaip.com\/intellepedia\/wp-json\/wp\/v2\/media?parent=113553"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bananaip.com\/intellepedia\/wp-json\/wp\/v2\/categories?post=113553"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bananaip.com\/intellepedia\/wp-json\/wp\/v2\/tags?post=113553"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Disclaimer<\/strong><\/h4>\n